단세포 분석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Single-Cell Analysis Market size is expected to reach USD 32.15 Billion in 2034 from USD 6.73 Billion (2025) growing at a CAGR of 18.97% during 2026-2034.

The global single-cell analysis market is experiencing rapid growth as researchers increasingly focus on studying individual cells to better understand biological processes and disease mechanisms. Single-cell analysis technologies allow scientists to examine genetic, protein, and metabolic characteristics at the cellular level. This approach provides valuable insights into complex biological systems that cannot be observed through traditional bulk analysis methods.

Advancements in genomics, transcriptomics, and high-throughput sequencing technologies are significantly driving market growth. These technologies enable researchers to analyze thousands of individual cells simultaneously, accelerating discoveries in areas such as cancer research, immunology, and neuroscience. Pharmaceutical and biotechnology companies are also adopting single-cell analysis to improve drug discovery and personalized medicine strategies.

In the future, the market is expected to grow as precision medicine and advanced biomedical research continue to evolve. Increasing investments in genomics research and the development of innovative analytical tools will further enhance the capabilities of single-cell technologies. As scientists continue exploring cellular diversity and disease pathways, single-cell analysis will play a critical role in advancing medical research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables
• Instruments

By Application

• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization
• Others

By Workflow

• Single Cell Isolation & Library Preparation
• Downstream Analysis
• Data Analysis

By End-use

• Academic And Research Laboratories
• Biotechnology And Pharmaceutical Companies
• Hospitals And Diagnostic Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, QIAGEN NV, BioRad Laboratories Inc, Illumina Inc, Merck KGaA, Becton, Dickinson and Company BD, Fluidigm Corporation Standard BioTools Inc, 10x Genomics Inc, BGI Genomics Co Ltd, Novogene Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Non-invasive Prenatal Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. In-vitro Fertilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Single Cell Isolation & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Downstream Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Academic And Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals And Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Workflow
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Workflow
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Workflow
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Workflow
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Workflow
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SINGLE-CELL ANALYSIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 QIAGEN N.V
  • 10.2.3 Bio-Rad Laboratories Inc
  • 10.2.4 Illumina Inc
  • 10.2.5 Merck KGaA
  • 10.2.6 Becton
  • 10.2.7 Dickinson And Company (BD)
  • 10.2.8 Fluidigm Corporation (Standard BioTools Inc.)
  • 10.2.9 10x Genomics Inc
  • 10.2.10 BGI Genomics Co. Ltd
  • 10.2.11 Novogene Co. Ltd